Ongoing Trials in Nephrology
Listed below is a selection of ongoing studies from a variety of sources including:
To search for registered clinical trials across a variety of registers, use the WHO International Clinical Trials Registry Platform Search Portal
For further information about the WHO Registry Platform, go to their website
Acute
Renal Failure | Chronic Kidney Disease
| Dialysis
Diabetic Nephropathy |
General Nephrology
Transplantation | Urinary Tract Infection |
Urology
Acute Renal Failure
Dialysis
Diabetic Nephropathy
General Nephrology
- Pirfenidone in
Focal Segmental Glomerulosclerosis Phase II Study[NCT00001959]
Source: ClinicalTrials.Gov
- Therapy of frequent relapsing, steroid-sensitive nephrotic syndrome in childhood: efficacy of mycophenolate mofetil
versus cyclosporin A[ISRCTN61976169]
Source: Current Controlled Trials
- Comparison of short course cyclophosphamide followed by mycophenolate mofetil versus long course cyclophosphamide in
the treatment of proliferative lupus nephritis[ISRCTN34634478]
Source: Current Controlled Trials
- A Prospective, Randomized, Active Controlled, Parallel Group, Multi-Center Trial to Assess the Efficacy and Safety of Mycophenolate Mofetil (MMF) in Inducing Response
and Maintaining Remission in Subjects With Lupus Nephritis[NCT00121082]
Source: ClinicalTrials.Gov
- Eplerenone,
ACE Inhibition and Albuminuria[NCT00315016]
Source: ClinicalTrials.Gov
- A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rituximab in
Subjects With ISN/RPS Class III or IV Lupus Nephritis[NCT00282347]
Source: ClinicalTrials.Gov
- A Randomized Controlled
Trial of Mycophenolate Mofetil in Patients With IgA Nephropathy[NCT00318474]
Source: ClinicalTrials.Gov
- An Open, Prospective Study to Assess the Efficacy and Safety of Tacrolimus Combined With Mycophenolate Mofetil in the Treatment of
Class III/IV/V Lupus Nephritis[NCT00298506]
Source: ClinicalTrials.Gov
- A Randomized, Double-Blind, Placebo-Controlled, Four-Arm,
Parallel-Group, Multicenter, Multinational Safety and Efficacy Trial of 100 Mg, 300
Mg and 900 Mg of LJP 394 in Systemic Lupus Erythematosus (SLE) Patients With a History
of Renal Disease[NCT00089804]
Source: ClinicalTrials.Gov
- Tacrolimus Treatment of Patients With
Idiopathic Focal Segmental Glomerulosclerosis[NCT00302536]
Source: ClinicalTrials.Gov
- Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During
Spironolactone Therapy[NCT00335413]
Source: ClinicalTrials.Gov
- Sirolimus (Rapamune®) for Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD):
a Randomized Controlled Study[NCT00346918]
Source: ClinicalTrials.Gov
- Tacrolimus for the
Treatment of Systemic Lupus Erythematosus With Membranous Nephritis[NCT00125307]
Source: ClinicalTrials.Gov
- Renal
Atherosclerotic Revascularization Evaluation: RAVE Study[NCT00127738]
Source: ClinicalTrials.Gov
Transplantation
|
